Titan America SA Common Shares (TTAM)
16.62
-0.30 (-1.77%)
NYSE · Last Trade: Dec 14th, 10:29 AM EST

Cystic-fibrosis-focused Sionna Therapeutics made its public debut this week, with an upsized public offering. Meanwhile, Titan America had a modest opening, just slightly higher than its initial pricing.
Via Talk Markets · February 9, 2025
